Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828350 | PMC |
| http://dx.doi.org/10.1007/s10147-016-1052-3 | DOI Listing |
Publication Analysis
Top Keywords
erratum final
4
final survival
4
survival jo22903
4
jo22903 phase
4
phase open-label
4
open-label study
4
study first-line
4
first-line erlotinib
4
erlotinib japanese
4
japanese patients
4
Similar Publications
Author Correction: Innovative boxing training program outperforms the traditional scapular stabilization training program in post-stroke patients.
Sci Rep
November 2024
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Eastern Mediterranean University, North Cyprus Via Mersin 10, Famagusta, Turkey.
ERRATUM: The impact of the final rinse on the cytoxicity of critical products submitted for processing.
Rev Esc Enferm USP
September 2024
[This corrects the article doi: https://doi.org/10.1590/S0080-623420150000700013] [This corrects the article doi: https://doi.
View Article and Find Full Text PDFCorrection to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study.
Ann Hematol
November 2024
Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!